Urol. praxi, 2012; 13(6): 236-237
Health-economics of intravesical therapy in bladder cancer
- nezávislý konzultant, Praha
Health-economics is one of the processes during the complex health-technology assessment. It supports rational resource allocation
in times of financial scarcity. Even in the Czech republic health-economic evaluations are receiving more attention from payers and decision
makers. The incidence of bladder cancer (BC) is increasing, requiring higher proportions of financial resources to be allocated to
costly treatment. In non-muscle invasive forms, intravesical instillation of chemotherapy and/or BCG vaccine has shown advantages
in terms of time to recurrence. The publication calculates costs for intravesical treatment in relation to progression-free-year gained.
Keywords: health-economics, bladder cancer, intravesical therapy
Published: November 1, 2012 Show citation
References
- Sangar VK, Ragavan N, Matanhelia SS, et al. The economic consequences of prostate and bladder cancer in the UK. BJU Int 2005; 95: 59-63.
Go to original source... 
Go to PubMed... - Sylvester R J, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J. Urol. 2004; 171: 2186-2190. Go to original source... Go to PubMed...
- Huncharek M, Kupelnick B. Impact of Intravesical Chemotherapy Versus BCG Immunotherapy on Recurrence of Superficial Transitional Cell Carcinoma of the Bladder: Metaanalytic Reevaluation. AmericanJ ournal of Clinical Oncology 2003; 26(4): 402-407. Go to original source... Go to PubMed...
- Boehle A, et al. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 2006; 169(1): 90-95. Go to original source...
- Shelley MD, Court JB, Kynaston H, et al. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer. Cochrane Database SystRev (England) 2003 pCD003231. Go to original source...
- Havránek O, et al. Komplikace intravezikální terapie svalovinu neinfiltrujícího karcinomu močového měchýře vakcínou BCG. Ces Urol 2010; 14(2): 92-98.
- Han RF, Pan JG. Canin travesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology 2006; 67(6): 1216-1223. Go to original source... Go to PubMed...
- Babjuk M, et al. Guidelines on Non-muscle-invasive bladder cancer. European Association of Urology 2012.